Research & Development

亚洲校园春色综合100狠狠干狠狠干图片友邦上周五破顶后连日回吐 现跌2%暂领跌蓝筹


  隨侍正要出去,卻看見披著大紅斗篷的霍去病已經進來了。   怪不得甦秦,張儀公孫龍這些家伙僅僅靠著一張嘴就能混的風生水起,甦秦一個破落戶居然能夠身配六國相印。亚洲校园春色综合100   血參可以肥你卓氏,雲瑯若能收為心腹,他可保你一世平安。狠狠干   這是沒辦法的事情,原本一個十三歲的小正太是沒有他腦子里這些亂七八糟的東西的。 狠狠干图片   說完,平叟就得意的捋捋胡須,腰板也似乎挺得更直了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo